Review



polyclonal rabbit anti-human fpr3 igg  (Absolute Biotech Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Absolute Biotech Inc polyclonal rabbit anti-human fpr3 igg
    Cytokine production of allergen-treated DCs silenced for <t>FPR3</t> expression and cocultured CD4 + CD45RA + T cells. A, Supernatants of DCs silenced for FPR3 expression or controls activated with lipocalins, as indicated, were analyzed by means of ELISA for IL-12 p70. B-D, Supernatants of day 5 cocultures of DCs silenced for FPR3 expression and treated with Can f 1 or Fel d 4, as indicated, and naive CD4 + CD45RA + T cells were analyzed for IL-13 (Fig 4, B ), IL-4 (Fig 4, C ), and IFN-γ (Fig 4, D ) content. ns , P >.05, * P <.05, ** P <.01, and *** P <.001.
    Polyclonal Rabbit Anti Human Fpr3 Igg, supplied by Absolute Biotech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polyclonal+rabbit+anti-human+fpr3+igg/pmc07115912-40-4-9?v=Absolute+Biotech+Inc
    Average 90 stars, based on 1 article reviews
    polyclonal rabbit anti-human fpr3 igg - by Bioz Stars, 2026-07
    90/100 stars

    Images

    1) Product Images from "Peptides from allergenic lipocalins bind to formyl peptide receptor 3 in human dendritic cells to mediate T H 2 immunity"

    Article Title: Peptides from allergenic lipocalins bind to formyl peptide receptor 3 in human dendritic cells to mediate T H 2 immunity

    Journal: The Journal of allergy and clinical immunology

    doi: 10.1016/j.jaci.2019.07.008

    Cytokine production of allergen-treated DCs silenced for FPR3 expression and cocultured CD4 + CD45RA + T cells. A, Supernatants of DCs silenced for FPR3 expression or controls activated with lipocalins, as indicated, were analyzed by means of ELISA for IL-12 p70. B-D, Supernatants of day 5 cocultures of DCs silenced for FPR3 expression and treated with Can f 1 or Fel d 4, as indicated, and naive CD4 + CD45RA + T cells were analyzed for IL-13 (Fig 4, B ), IL-4 (Fig 4, C ), and IFN-γ (Fig 4, D ) content. ns , P >.05, * P <.05, ** P <.01, and *** P <.001.
    Figure Legend Snippet: Cytokine production of allergen-treated DCs silenced for FPR3 expression and cocultured CD4 + CD45RA + T cells. A, Supernatants of DCs silenced for FPR3 expression or controls activated with lipocalins, as indicated, were analyzed by means of ELISA for IL-12 p70. B-D, Supernatants of day 5 cocultures of DCs silenced for FPR3 expression and treated with Can f 1 or Fel d 4, as indicated, and naive CD4 + CD45RA + T cells were analyzed for IL-13 (Fig 4, B ), IL-4 (Fig 4, C ), and IFN-γ (Fig 4, D ) content. ns , P >.05, * P <.05, ** P <.01, and *** P <.001.

    Techniques Used: Expressing, Enzyme-linked Immunosorbent Assay

    Effect of WRW4 on FPR3-induced T H 2 bias. A, WRW4 (1 μmol/L) was added before addition of Can f 1 digest and ionomycin to HEK 293–FPR3 cells. B, IL-12 production by DCs treated with allergenic and nonallergenic lipocalins in the presence or absence of 1 μmol/L WRW4, as indicated. C-E, IL-13 (Fig 5, C ), IL-4 (Fig 5, D ), and IFN-γ (Fig 5, E ) content in supernatants of cocultures of CD4 + CD45RA + naive T H cells and DCs treated with allergenic and nonallergenic lipocalins in the presence or absence of WRW4, as indicated. ns, P >.05, ** P <.01, and *** P <.001.
    Figure Legend Snippet: Effect of WRW4 on FPR3-induced T H 2 bias. A, WRW4 (1 μmol/L) was added before addition of Can f 1 digest and ionomycin to HEK 293–FPR3 cells. B, IL-12 production by DCs treated with allergenic and nonallergenic lipocalins in the presence or absence of 1 μmol/L WRW4, as indicated. C-E, IL-13 (Fig 5, C ), IL-4 (Fig 5, D ), and IFN-γ (Fig 5, E ) content in supernatants of cocultures of CD4 + CD45RA + naive T H cells and DCs treated with allergenic and nonallergenic lipocalins in the presence or absence of WRW4, as indicated. ns, P >.05, ** P <.01, and *** P <.001.

    Techniques Used:



    Similar Products

    polyclonal rabbit anti-human fpr3 igg  (Absolute Biotech Inc)
    90
    Absolute Biotech Inc polyclonal rabbit anti-human fpr3 igg
    Cytokine production of allergen-treated DCs silenced for <t>FPR3</t> expression and cocultured CD4 + CD45RA + T cells. A, Supernatants of DCs silenced for FPR3 expression or controls activated with lipocalins, as indicated, were analyzed by means of ELISA for IL-12 p70. B-D, Supernatants of day 5 cocultures of DCs silenced for FPR3 expression and treated with Can f 1 or Fel d 4, as indicated, and naive CD4 + CD45RA + T cells were analyzed for IL-13 (Fig 4, B ), IL-4 (Fig 4, C ), and IFN-γ (Fig 4, D ) content. ns , P >.05, * P <.05, ** P <.01, and *** P <.001.
    Polyclonal Rabbit Anti Human Fpr3 Igg, supplied by Absolute Biotech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polyclonal+rabbit+anti-human+fpr3+igg/pmc07115912-40-4-9?v=Absolute+Biotech+Inc
    Average 90 stars, based on 1 article reviews
    polyclonal rabbit anti-human fpr3 igg - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Cytokine production of allergen-treated DCs silenced for FPR3 expression and cocultured CD4 + CD45RA + T cells. A, Supernatants of DCs silenced for FPR3 expression or controls activated with lipocalins, as indicated, were analyzed by means of ELISA for IL-12 p70. B-D, Supernatants of day 5 cocultures of DCs silenced for FPR3 expression and treated with Can f 1 or Fel d 4, as indicated, and naive CD4 + CD45RA + T cells were analyzed for IL-13 (Fig 4, B ), IL-4 (Fig 4, C ), and IFN-γ (Fig 4, D ) content. ns , P >.05, * P <.05, ** P <.01, and *** P <.001.

    Journal: The Journal of allergy and clinical immunology

    Article Title: Peptides from allergenic lipocalins bind to formyl peptide receptor 3 in human dendritic cells to mediate T H 2 immunity

    doi: 10.1016/j.jaci.2019.07.008

    Figure Lengend Snippet: Cytokine production of allergen-treated DCs silenced for FPR3 expression and cocultured CD4 + CD45RA + T cells. A, Supernatants of DCs silenced for FPR3 expression or controls activated with lipocalins, as indicated, were analyzed by means of ELISA for IL-12 p70. B-D, Supernatants of day 5 cocultures of DCs silenced for FPR3 expression and treated with Can f 1 or Fel d 4, as indicated, and naive CD4 + CD45RA + T cells were analyzed for IL-13 (Fig 4, B ), IL-4 (Fig 4, C ), and IFN-γ (Fig 4, D ) content. ns , P >.05, * P <.05, ** P <.01, and *** P <.001.

    Article Snippet: Immunostaining was performed with polyclonal rabbit anti-human FPR3 IgG (LSBio, Seattle, Wash), followed by Alexa Fluor 488–conjugated goat antirabbit antibody (Invitrogen Life Technologies, Eugene, Oreg).

    Techniques: Expressing, Enzyme-linked Immunosorbent Assay

    Effect of WRW4 on FPR3-induced T H 2 bias. A, WRW4 (1 μmol/L) was added before addition of Can f 1 digest and ionomycin to HEK 293–FPR3 cells. B, IL-12 production by DCs treated with allergenic and nonallergenic lipocalins in the presence or absence of 1 μmol/L WRW4, as indicated. C-E, IL-13 (Fig 5, C ), IL-4 (Fig 5, D ), and IFN-γ (Fig 5, E ) content in supernatants of cocultures of CD4 + CD45RA + naive T H cells and DCs treated with allergenic and nonallergenic lipocalins in the presence or absence of WRW4, as indicated. ns, P >.05, ** P <.01, and *** P <.001.

    Journal: The Journal of allergy and clinical immunology

    Article Title: Peptides from allergenic lipocalins bind to formyl peptide receptor 3 in human dendritic cells to mediate T H 2 immunity

    doi: 10.1016/j.jaci.2019.07.008

    Figure Lengend Snippet: Effect of WRW4 on FPR3-induced T H 2 bias. A, WRW4 (1 μmol/L) was added before addition of Can f 1 digest and ionomycin to HEK 293–FPR3 cells. B, IL-12 production by DCs treated with allergenic and nonallergenic lipocalins in the presence or absence of 1 μmol/L WRW4, as indicated. C-E, IL-13 (Fig 5, C ), IL-4 (Fig 5, D ), and IFN-γ (Fig 5, E ) content in supernatants of cocultures of CD4 + CD45RA + naive T H cells and DCs treated with allergenic and nonallergenic lipocalins in the presence or absence of WRW4, as indicated. ns, P >.05, ** P <.01, and *** P <.001.

    Article Snippet: Immunostaining was performed with polyclonal rabbit anti-human FPR3 IgG (LSBio, Seattle, Wash), followed by Alexa Fluor 488–conjugated goat antirabbit antibody (Invitrogen Life Technologies, Eugene, Oreg).

    Techniques: